Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.10, 2007-10, pp. : 1683-1691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma

By Jamal-Hanjani Mariam Pettengell Ruth

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1441-1448

Informa Healthcare

Access to resources Recommend Favorite

Pixantrone for the treatment of aggressive non-Hodgkin lymphoma

By Mukherji Deborah Pettengell Ruth

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1915-1923

Informa Healthcare

Access to resources Recommend Favorite

The role of pixantrone in the treatment of non-Hodgkin’s lymphoma

By Borchmann Peter

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1055-1061

Informa Healthcare

Access to resources Recommend Favorite

Radioimmunotherapy of Non-Hodgkin's Lymphomas

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1293-1300

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Hodgkin's Lymphomas

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 4, 2008-04 ,pp. : 356-356

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite